Could the principles of open source and open innovation transform the future of clinical research? Come hear thought leader and innovator Dr. Tomasz Sablinski deliver the keynote presentation titled “Breaking Barriers: Forging a New Model for Clinical Development” at the 2012 OpenClinica Conference on April 23rd in Boston.
The world has shown that it is possible to harness the power of crowds to deliver incredibly successful innovation and services (think Facebook, Wikipedia, Linux). However, this style of innovation is relatively absent within the domain of clinical research. Sablinski believes the time may be ripe to borrow from the principles of open source and telemedicine in order to create a new, more effective model for clinical development.
Dr. Sablinski’s ideas have profound implications. However, while bold and thought provoking, they are more than academic. He puts his money where his mouth is–Sablinski’s start-up company, Transparency Life Sciences, has set out to increase the efficiency of clinical development leveraging open principles that turn much of the current way of thinking on its head.
Dr. Sablisnki’s assessments of the current state of clinical development are based on over 30 years in the field, as a practicing physician, basic researcher, drug developer, investor, and now, entrepreneur. He has served as a researcher at Harvard Medical School, a Medical Director at Parexel, VP of Clinical Development at Novartis, and Head of Development and Managing Director at private equity firm Celtic Therapeutics.
We look forward to hosting Dr. Sablinski at this year’s OpenClinica Global Conference!
– Ben Baumann
Chair, OpenClinica Conference Committee